Biopharma Leaders Discuss Pharma’s Future at Pharmaceutical Strategic Alliances in New York
BRIDGEWATER, New Jersey, August 8, 2011 /PRNewswire/ –
Elsevier Business Intelligence [http://www.elsevierbi.com ], the
biopharma industry’s leading provider of strategic business intelligence and
conferences, is hosting Windhover’s 21st Pharmaceutical Strategic Alliances
[http://www.windhover.com/psa ] (PSA) September 21-23, 2011 at the
Millennium Broadway in New York, NY.
PSA is the only conference of its kind to provide direct access to such
a diverse mix of pharma’s top talent. It’s an opportunity to hear first-hand
from some of the industry’s most influential minds and leading experts.
Chief Executive Officers Lamberto Andreotti of Bristol-Myers Squibb and
George Scangos of Biogen Idec are just two of the speakers providing
perspectives – and solutions – to the top challenges facing biopharma
companies big and small.
Other leading experts from firms such as Pfizer, Johnson and Johnson,
Roche and Merck will present information on other important topics facing
the biopharma industry, including:
- R&D Evolution: How Big Pharma Can Get It Right; - Lessons Learned from the Changing Oncology Landscape: Industry Perspectives; - Biosimilars: What You Need To Know Now; - Reimagining Business Development, and many more.
In addition to moderating strategic panels spanning R&D through
commercialization, IN VIVO’s editorial team will also present an overview of
current deal making trends, providing insights into top trends like academic
alliances, creative deal structures, and the importance of innovation in
today’s payor-dominated world.
“Pharmaceutical Strategic Alliances is a rare opportunity to provide a
discussion of the various, most promising solutions to the industry’s
toughest challenges. Call it a tool box for growth – and for those most in
need, pharma’s survival kit,” said Elsevier Business Intelligence’s Chris
Morrison, Editor-in-Chief, Biopharma and Consumer Products.
To learn more about panel topics and keynote talks, visit:
About Windhover Conferences and Elsevier Business Intelligence
Windhover Conferences is an Elsevier Business Intelligence company, the
leading provider of business intelligence and analysis to senior executives
in the medical device, pharmaceutical, and biotechnology industries.
Publishers of The Pink Sheet, IN VIVO: The Business & Medicine Report,
PharmAsia News, The Tan Sheet”,Start-Up: Emerging Medical Ventures, and The
RPM Report: Regulation – Policy – Market Access, Elsevier Business
Intelligence and Windhover also host a variety of industry meetings and
webinars in both medical device and pharma/biotech, and produce a wide array
of market research reports. For more on the companies’ products and
services, please visit http://www.elsevierbi.com.
Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier’s online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai’s Pinpoint Review [http://www.medai.com ], which help research and
health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier
[http://www.elsevier.com ] employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Media contact Dianna Flanick Vice President, Sales & Marketing Elsevier Business Intelligence +1-908-547-2141 firstname.lastname@example.org